Tata group to launch India’s first low cost Covid-19 test ‘Feluda’ – Mint
The Drug Controller General of India (DCGI) on Saturday gave approval for the commercial launch of India’s first Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) coronavirus…
